INNOCAN PHARMA
Cannabinoids interact with the endocannabinoid receptor system, which is located throughout the body and plays an important role in many processes. InnoCan aims to harness the power of cannabinoids to target a wide variety of health problems. InnoCan plans to initially innovate new dermatology treatments, where research shows topical cannabinoid-combined treatments are highly effective.
INNOCAN PHARMA
Industry:
Biotechnology Health Care Medical Pharmaceutical Therapeutics
Founded:
2018-01-01
Address:
Herzliya, Tel Aviv, Israel
Country:
Israel
Website Url:
http://www.innocanpharma.com
Total Employee:
1+
Status:
Active
Contact:
+972.54.471.1171
Email Addresses:
[email protected]
Total Funding:
3.54 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Current Employees Featured
Founder
Stock Details
Investors List
PipelBiz.com
PipelBiz.com investment in Equity Crowdfunding - InnoCan Pharma
Official Site Inspections
http://www.innocanpharma.com Semrush global rank: 2.71 M Semrush visits lastest month: 6.07 K
- Host name: 172.67.205.80
- IP address: 172.67.205.80
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "InnoCan Pharma"
InnoCan Pharma - LinkedIn
InnoCan Pharma | 2,359 followers on LinkedIn. (CSE:INNO) (FSE:IP4) (OTCQB:INNPF) | InnoCan Pharma is a pharmaceutical company specializing in developing novel therapeutics that harness the unique healing properties of Cannabinoids to improve quality of life. OUR …See details»
InnoCan Pharma - Crunchbase Company Profile
InnoCan Pharma is a pharma tech company.that develops novel therapeutics platforms and products to improve quality of life.See details»
BOARD OF DIRECTORS - Innocan Pharma
BOARD OF DIRECTORS Our board of directors bring tremendous experience, visionary thinking and a shared commitment to excellence, creativity and innovationSee details»
Innocan Pharma Corp (INNO-CN) Profile - The Globe and Mail
See the company profile for Innocan Pharma Corp (INNO-CN) including business summary, industry/sector information, business summary, corporate governance, key executives.See details»
InnoCan Pharma (CSE:INNO) Company Profile & Description
Jul 30, 2025 Company profile for InnoCan Pharma Corporation (CSE:INNO) with a description, list of executives, contact details and other key facts.See details»
Innocan Pharma - Craft
Innocan Pharma $13.66 m in annual revenue in FY 2023. See insights on Innocan Pharma including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
InnoCan Pharma Company Profile | Management and Employees …
InnoCan Pharma Profile and History Innocan Pharma is focused on innovative non-opioid solutions for chronic pain management and wellness, catering to both human and animal health. The company specializes in drug development and conducts pre-clinical studies to ensure the …See details»
InnoCan Pharma - Israeli Startup | Startup Nation Finder
Jun 20, 2025 Innocan Pharma is a pharmaceutical technology company that operates under two main segments: Pharmaceuticals and Consumer Wellness. In the Pharmaceuticals segment, Innocan focuses on developing innovative drug …See details»
INNOCAN PHARMA CORPORATION
Opinion We have audited the consolidated financial statements of Innocan Pharma Corporation (the "Company"), which comprise the consolidated statement of financial position as at December 31, 2024, and the consolidated statement of comprehensive loss, changes in equity and cash …See details»
Innocan Pharma - Overview, News & Similar companies - ZoomInfo
Dec 12, 2023 View Innocan Pharma (www.innocanpharma.com) location in Quebec, Canada , revenue, industry and description. Find related and similar companies as well as employees by title and much more.See details»
INNOCAN PHARMA CORPORATION - MarketScreener.com
Sep 24, 2019 Innocan Pharma Corporation is an Israel-based company active in the pharmaceuticals and wellness sectors. In the pharmaceuticals sector, the Company aims to provide a safe, non-opioid chronic pain management solutions for both animals and humans. …See details»
Innocan Pharma Corporation Company Profile - Dun & Bradstreet
Innocan Pharma Corporation Company Profile | Calgary, AB, Canada | Competitors, Financials & Contacts - Dun & BradstreetFinancial Statements Dun & Bradstreet collects private company financials for more than 23 million companies worldwide. Find out more. Get a D&B credit …See details»
InnoCan Pharma - Profiles & Contacts - Crunchbase
InnoCan Pharma is a pharma tech company.that develops novel therapeutics platforms and products to improve quality of life.See details»
Presentation | Innocan Pharma
Accessibility Toolbar close Toggle the visibility of the Accessibility ToolbarSee details»
News & Events | Innocan Pharma
Innocan Pharma closes financing while launching new commercial website shop.innocanpharma.com Read moreSee details»
SCIENCE | Innocan Pharma
At Innocan, we are committed to revolutionizing chronic pain treatment through advanced scientific innovation. Our unique injectable delivery platform, LPT-CBD, utilizes liposome technology that enables exact dosing and controlled release of synthetic Cannabidiol (CBD) …See details»
InnoCan Pharma Corporation - Executive Bio, Top Executies, and ...
InnoCan Pharma Corporation, a pharmaceutical company, focuses on the development of various drug delivery platforms combining cannabidiol (CBD) with other pharmaceutical ingredients in Israel.See details»
Innocan Pharma - VentureRadar
Dansk Biotek Unknown n/a DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for biotechnology research, development and production in Denmark and perform common business interests in this context, both nationally …See details»
Innocan Pharma Announces First Quarter 2025 Financial
May 28, 2025 The Company's full set of unaudited condensed interim consolidated financial statements for the three months ended March 31, 2025, and accompanying management's discussion and analysis can be ...See details»
INVESTORS - Innocan Pharma
Innocan Pharma gibt die öffentliche Einreichung der Registrierungserklärung für den geplanten Börsengang in den USA bekanntSee details»